Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity. https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4 📖Paperback: https://amzn.to/4gAXrz4 💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP USE CODE "OTP10" to save 10%. SOCIALS: 📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1 👾: https://discord.gg/ZHeUh7WV 📺: https://youtube.com/@ManOnTheMounjaro?feature=shared ❌: https://x.com/manonthepen?s=21 💻: https://www.onthepen.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.